FCEUX
Price
$19.53
Change
+$0.05 (+0.26%)
Updated
Nov 19 closing price
Net Assets
1.11B
VFIAX
Price
$613.90
Change
+$2.31 (+0.38%)
Updated
Nov 19 closing price
Net Assets
1.46T
Interact to see
Advertisement

FCEUX vs VFIAX

Header iconFCEUX vs VFIAX Comparison
Open Charts FCEUX vs VFIAXBanner chart's image
Franklin U.S. Core Equity Advisor
Price$19.53
Change+$0.05 (+0.26%)
VolumeN/A
Net Assets1.11B
Vanguard 500 Index Admiral
Price$613.90
Change+$2.31 (+0.38%)
VolumeN/A
Net Assets1.46T
FCEUX vs VFIAX Comparison Chart in %
View a ticker or compare two or three
VS
FCEUX vs. VFIAX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FCEUX is a Hold and VFIAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFIAX has more cash in the bank: 1.46T vs. FCEUX (1.11B). FCEUX (1.14) and VFIAX (1.11) have matching dividends . FCEUX was incepted earlier than VFIAX: FCEUX (6 years) vs VFIAX (25 years). VFIAX (0.04) is less costly to investors than FCEUX (0.01). FCEUX is a more actively managed with annual turnover of: 76.33 vs. VFIAX (2.00). FCEUX has a lower initial minimum investment than VFIAX: FCEUX (0) vs VFIAX (3000). FCEUX annual gain was more profitable for investors over the last year : 13.92 vs. VFIAX (11.89). VFIAX return over 5 years is better than : 86.13 vs. FCEUX (71.77).
FCEUXVFIAXFCEUX / VFIAX
Total Expense Ratio0.000.04-
Annual Report Gross Expense Ratio0.010.0425%
Fund Existence6 years25 years-
Gain YTD14.36912.722113%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.11B1.46T0%
Annual Yield % from dividends1.141.11103%
Returns for 1 year13.9211.89117%
Returns for 3 years59.5366.9889%
Returns for 5 years71.7786.1383%
Returns for 10 yearsN/A216.78-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ORKA28.200.75
+2.73%
Oruka Therapeutics Inc
LRMR3.450.06
+1.92%
Larimar Therapeutics
PG146.99N/A
N/A
Procter & Gamble Company
INLX8.94-0.04
-0.45%
Intellinetics
GGB3.46-0.02
-0.57%
Gerdau SA